Isomorphic Labs aims to 'solve all disease' with generative AI built beyond AlphaFold
ns123abc · x · 2026-10-08
Isomorphic Labs outlines its mission of building on and beyond the Nobel-winning AlphaFold system to reinvent drug discovery. Its team of drug discovery and ML experts has built predictive and generative AI models to design novel molecules and anticipate drug performance, and it recently joined the Virtual Biology Initiative to build foundational data for disease-predicting AI models.
More from Companies & People
- Hesamation Mocks OpenAI for Turning Good-Faith Security Researchers Into Critics — Hesamation · 2026-10-08
- E2E self-driving startup Wayve lands Stellantis deal after Nissan, claims it beat Tesla to E2E — alexgkendall · 2026-10-08
- Extropic CEO Guillaume Verdon: 14-hour days as startup claims 'insane progress' — beffjezos · 2026-10-08
- Cognizant to Hire 1,500 US Graduates; Devin Cut Freight Firm's Rebuild Costs 37% — shashib · 2026-10-08
- Cisco Brings Claude Managed Agents to Webex With Its Own Governance Layer — shashib · 2026-10-08
- Claude Code lead resets usage limits after community vote: users pick capacity over new features — CurieuxExplorer · 2026-10-08